Astellas seeking Japanese approval for ipragliflozin

Astellas Pharma Inc. (Tokyo:4503) submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for ipragliflozin to treat Type II diabetes. Astellas is co-developing the ...